It is well established that low levels of HDL-C are a risk factor for NAFLD (20, 21), and elevated ALT levels significantly increase NAFLD risk, even within the normal range for ALT (12–15, 34). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.